ABL1 and breast cancer: To gain insights into previously unveiled molecular mechanisms of BC-transformation in miR-142 deficient CML mice, we elected to conduct “bulk” and sc- RNA-seq analyses on miR-142−/−BCR-ABL LSKs vs miR-142+/+BCR-ABL LSKs.